PRKAA1 and inflammatory bowel disease: Our analysis clearly revealed altered metabolism in the colon of IBD patients, related to the loss of active AMPK and insulin production, two outcomes that will significantly contribute to the metabolic distress syndrome in IBD patients and affect their ability to recover.